Bezuclastinib for immune complex diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Aug 2021: Trial registered, NCT04996875
  2. 9 Nov 2021: Trial started, NCT04996875

The trials

NCT04996875: (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

State
Under way
Phase
Phase 2
People
140 planned
Started
9 Nov 2021
Primary completion
19 Sep 2025
Arms
bezuclastinib
Results
None posted
  1. 9 Aug 2021: Trial registered
  2. 9 Nov 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.